Bioequivalence/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: encapsulating subpages template in noinclude tag) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 18: | Line 18: | ||
{{r|Generic drug}} | {{r|Generic drug}} | ||
{{Bot-created_related_article_subpage}} | |||
<!-- Remove the section above after copying links to the other sections. --> | <!-- Remove the section above after copying links to the other sections. --> | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Iron deficiency anemia}} | |||
Latest revision as of 17:01, 18 July 2024
- See also changes related to Bioequivalence, or pages that link to Bioequivalence or to this page or whose text contains "Bioequivalence".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Bioequivalence. Needs checking by a human.
- Bioavailability [r]: An objective measurement of the availability, of target tissues, of the active ingredient of a drug or nutrient administered to a living organism [e]
- Food and Drug Administration [r]: The agency of the United States Department of Health and Human Services responsible for regulating food, dietary supplements, drugs, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics. [e]
- Generic drug [r]: Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies. [e]
- Iron deficiency anemia [r]: Anaemia resulting from a deficiency of iron, characterized by hypochromic microcytic erythrocytes and a normoblastic reaction of the bone marrow. [e]